NIH-funded research R01 grant

Detection of placental blood flow patterns to spot preeclampsia and fetal growth issues

Official title: Detection of Preeclampsia and Fetal Growth Restriction Based on Simultaneous Assessment of Maternal and Fetal Blood Flow Components

Funded at University of Michigan at Ann Arbor · NIH-11319065 · Data updated 2026-11-12

A non-invasive ultrasound method analyzes maternal and fetal blood flow to help detect risk of preeclampsia and fetal growth restriction in pregnancy.

More Preeclampsia research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Michigan at Ann Arbor
NIH-funded
Lab location1 site (Ann Arbor, United States)
Project startJuly 8, 2026
Project endJune 30, 2031
Funding year2026
Award (this year)$598,644
NIH project number1R01HD118657-01A1
Project IDNIH-11319065 on NIH RePORTER

Who could benefit from this research

Could help

Pregnant individuals, including those with suspected or confirmed FGR or preeclampsia, and those with normal pregnancies, may participate.

Less likely to help

Some participants may not show clear differences in blood-flow patterns or may not receive direct changes to their care based on the results.

What this research studies

This project will use advanced 3D ultrasound and spectral analysis of the umbilical vein pulse wave to measure both maternal and fetal blood flow in the placenta over time. Researchers will compare the waves’ spectral envelopes and compute ratios that may distinguish normal pregnancies from those affected by FGR or preeclampsia. The goal is to provide early, safe, non-invasive insights to guide care and test potential treatments in real time. The study includes pregnant people with normal pregnancies as well as those with FGR or preeclampsia. 3D color flow ultrasound will be used with standardized methods to collect and analyze data.

Why it matters

Potential benefit: If successful, this approach could enable earlier detection and better management of FGR and preeclampsia through non-invasive monitoring.

How similar studies have gone: Preliminary data suggest that placental blood-flow patterns can differentiate normal from high-risk pregnancies using spectral analyses.

Where this research is happening

  • University of Michigan at Ann Arbor
    Ann Arbor, United States
    Active

Researchers

  • Principal investigator: Kripfgans, Oliver D — University of Michigan at Ann Arbor
  • Study coordinator: Kripfgans, Oliver D

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.